Blume Capital Management, Inc.

Position in SNY — Sanofi

CIK 1587192 BERKELEY, CA

Position in SNY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,034,071

-$304,152 QoQ

Shares Held

47,681

-1.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#178

of 712 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. SNY ranks #3 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	45,083	$11,449,729
2	PFE	Pfizer Inc	241,130	$5,806,410
3	SNY	Sanofi This page	47,681	$2,034,071
4	GILD	Gilead Sciences, Inc.	3,160	$399,234
5	AMGN	Amgen Inc	530	$191,923
6	MRK	Merck & Co., Inc.	1,400	$179,900
7	LLY	ELI LILLY & Co	60	$71,965
8	BMY	Bristol Myers Squibb Co	1,054	$60,731

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,034,071	47,681	-1.8%	Shares	Sole	2026-07-27
2026-03-31	$2,338,223	48,531	+88.4%	Shares	Sole	2026-05-01
2025-12-31	$1,248,620	25,766	+2.0%	Shares	Sole	2026-02-05
2025-09-30	$1,192,555	25,266	+315725.0%	Shares	Sole	2025-11-06
2025-06-30	$386	8	-99.9%	Shares	Sole	2025-07-30
2024-06-30	$422,609	8,710	0.0%	Shares	Sole	2024-08-05
2024-03-31	$423,306	8,710	+4255.0%	Shares	Sole	2024-05-02
2022-09-30	$7,604	200	0.0%	Shares	Sole	2022-11-15
2022-06-30	$10,006	200	0.0%	Shares	Sole	2022-08-11
2022-03-31	$10,268	200	-99.6%	Shares	Sole	2022-05-12
2021-12-31	$2,635,260	52,600	+5160.0%	Shares	Sole	2022-02-07
2021-09-30	$48,210	1,000	-33.3%	Shares	Sole	2021-11-12
2021-06-30	$78,990	1,500	-12.9%	Shares	Sole	2021-08-10
2021-03-31	$85,170	1,722	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.